Patricia L. Allen - 12 Feb 2026 Form 4 Insider Report for Zenas BioPharma, Inc. (ZBIO)

Reporting relationship: Director
Issuer ticker: ZBIO
Reported as of: 12 Feb 2026
Net transaction value: +$499,746
SEC form: 4
Accepted by SEC: 13 Feb 2026, 17:06:22 UTC
Prior SEC filing: 12 Jun 2025
Next SEC filing: 17 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Chase Jayasekera, Attorney-in-Fact

Key filing fact

Patricia L. Allen filed Form 4 for Zenas BioPharma, Inc. (ZBIO) on 13 Feb 2026.

Key facts

This page summarizes Patricia L. Allen's Form 4 filing for Zenas BioPharma, Inc. (ZBIO).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Feb 2026, 17:06.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: +$499,746.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001348587 Primary reporting owner

Allen Patricia L

Relationship: Director
Address: C/O ZENAS BIOPHARMA, INC., 852 WINTER STREET, SUITE 250, WALTHAM
Signature: By: /s/ Chase Jayasekera, Attorney-in-Fact
Signature date: 13 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZBIO transaction

Common Stock

Purchase

Transaction value: $118,850
Shares: +5,000
Change %
Price: $23.77
Shares after: 5,000
Date: 12 Feb 2026
Ownership: Direct
Footnotes: F1

ZBIO transaction

Common Stock

Purchase

Transaction value: $138,738
Shares: +5,700
Change %: +114%
Price: $24.34
Shares after: 10,700
Date: 12 Feb 2026
Ownership: Direct
Footnotes: F2

ZBIO transaction

Common Stock

Purchase

Transaction value: $132,500
Shares: +5,000
Change %: +47%
Price: $26.50
Shares after: 15,700
Date: 12 Feb 2026
Ownership: Direct

ZBIO transaction

Common Stock

Purchase

Transaction value: $109,658
Shares: +4,160
Change %: +26%
Price: $26.36
Shares after: 19,860
Date: 13 Feb 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $23.38 to $24.07, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Footnote F2

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $24.12 to $24.7, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.